281 related articles for article (PubMed ID: 8709265)
1. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues.
Yang Y; Su Q; Grewal IS; Schilz R; Flavell RA; Wilson JM
J Virol; 1996 Sep; 70(9):6370-7. PubMed ID: 8709265
[TBL] [Abstract][Full Text] [Related]
2. Th2-dependent B cell responses in the absence of CD40-CD40 ligand interactions.
Chirmule N; Tazelaar J; Wilson JM
J Immunol; 2000 Jan; 164(1):248-55. PubMed ID: 10605018
[TBL] [Abstract][Full Text] [Related]
3. Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig.
Jooss K; Turka LA; Wilson JM
Gene Ther; 1998 Mar; 5(3):309-19. PubMed ID: 9614550
[TBL] [Abstract][Full Text] [Related]
4. Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver.
Kay MA; Meuse L; Gown AM; Linsley P; Hollenbaugh D; Aruffo A; Ochs HD; Wilson CB
Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4686-91. PubMed ID: 9114052
[TBL] [Abstract][Full Text] [Related]
5. CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40.
Yang Y; Wilson JM
Science; 1996 Sep; 273(5283):1862-4. PubMed ID: 8791591
[TBL] [Abstract][Full Text] [Related]
6. Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell responses.
Andreasen SO; Christensen JE; Marker O; Thomsen AR
J Immunol; 2000 Apr; 164(7):3689-97. PubMed ID: 10725727
[TBL] [Abstract][Full Text] [Related]
7. CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions.
Oxenius A; Campbell KA; Maliszewski CR; Kishimoto T; Kikutani H; Hengartner H; Zinkernagel RM; Bachmann MF
J Exp Med; 1996 May; 183(5):2209-18. PubMed ID: 8642330
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the immune response after local delivery of recombinant adenovirus in murine pancreas and successful strategies for readministration.
McClane SJ; Chirmule N; Burke CV; Raper SE
Hum Gene Ther; 1997 Dec; 8(18):2207-16. PubMed ID: 9449374
[TBL] [Abstract][Full Text] [Related]
9. Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung.
Jooss K; Yang Y; Wilson JM
Hum Gene Ther; 1996 Aug; 7(13):1555-66. PubMed ID: 8864756
[TBL] [Abstract][Full Text] [Related]
10. Readministration of adenovirus vector in nonhuman primate lungs by blockade of CD40-CD40 ligand interactions.
Chirmule N; Raper SE; Burkly L; Thomas D; Tazelaar J; Hughes JV; Wilson JM
J Virol; 2000 Apr; 74(7):3345-52. PubMed ID: 10708452
[TBL] [Abstract][Full Text] [Related]
11. Role of E4 in eliciting CD4 T-cell and B-cell responses to adenovirus vectors delivered to murine and nonhuman primate lungs.
Chirmule N; Hughes JV; Gao GP; Raper SE; Wilson JM
J Virol; 1998 Jul; 72(7):6138-45. PubMed ID: 9621078
[TBL] [Abstract][Full Text] [Related]
12. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.
Yang Y; Haecker SE; Su Q; Wilson JM
Hum Mol Genet; 1996 Nov; 5(11):1703-12. PubMed ID: 8922997
[TBL] [Abstract][Full Text] [Related]
13. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.
Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH
Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin augments cytotoxic T-lymphocyte-mediated antitumor immunity in poorly immunogenic murine lung cancer.
Merritt RE; Mahtabifard A; Yamada RE; Crystal RG; Korst RJ
J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1609-17. PubMed ID: 14666041
[TBL] [Abstract][Full Text] [Related]
15. Immunologic barriers to hepatic adenoviral gene therapy for transplantation.
DeMatteo RP; Chu G; Ahn M; Chang E; Burke C; Raper SE; Barker CF; Markmann JF
Transplantation; 1997 Jan; 63(2):315-9. PubMed ID: 9020337
[TBL] [Abstract][Full Text] [Related]
16. CD40 ligand (CD154) enhances the Th1 and antibody responses to respiratory syncytial virus in the BALB/c mouse.
Tripp RA; Jones L; Anderson LJ; Brown MP
J Immunol; 2000 Jun; 164(11):5913-21. PubMed ID: 10820273
[TBL] [Abstract][Full Text] [Related]
17. "Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung.
Croyle MA; Chirmule N; Zhang Y; Wilson JM
J Virol; 2001 May; 75(10):4792-801. PubMed ID: 11312351
[TBL] [Abstract][Full Text] [Related]
18. Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors.
Manning WC; Zhou S; Bland MP; Escobedo JA; Dwarki V
Hum Gene Ther; 1998 Mar; 9(4):477-85. PubMed ID: 9525309
[TBL] [Abstract][Full Text] [Related]
19. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Buhlman J; Xu J; Flavell RA; Korngold R; Noelle R; Vallera DA
J Immunol; 1997 Jan; 158(1):29-39. PubMed ID: 8977172
[TBL] [Abstract][Full Text] [Related]
20. Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver.
Alzuguren P; Hervas-Stubbs S; Gonzalez-Aseguinolaza G; Poutou J; Fortes P; Mancheno U; Bunuales M; Olagüe C; Razquin N; Van Rooijen N; Enguita M; Hernandez-Alcoceba R
Liver Int; 2015 Apr; 35(4):1274-89. PubMed ID: 24754307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
